Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non-Cirrhotic”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT07687758
What this trial is testing

Non-Invasive Risk Stratification for Hepatocellular Carcinoma in HCV-Related Compensated Advanced Chronic Liver Disease Following Sustained Virological Response: Validation of the aMAP Score

Who this might be right for
Hepatitis C Virus InfectionCompensated Advanced Chronic Liver DiseaseHepatocellular Carcinoma (HCC)
Siriraj Hospital 571
Not applicableUnknownNCT05719857
What this trial is testing

Hepatic Venous Pressure Gradient and Elastography in Porto-sinusoidal Vascular Disorder

Who this might be right for
Portal HypertensionNon-Cirrhotic Portal HypertensionNon-Cirrhotic Portal Fibrosis+7 more
Universidade Federal do Rio de Janeiro 50
Early research (Phase 1)Looking for participantsNCT07229911
What this trial is testing

TAK-781 in Healthy Volunteers and in Participants With Non-Cirrhotic Primary Sclerosing Cholangitis (PSC)

Who this might be right for
Healthy VolunteersPrimary Sclerosing Cholangitis
Takeda 134
Large-scale testing (Phase 3)Looking for participantsNCT06215716
What this trial is testing

A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis

Who this might be right for
NASH With FibrosisMASH With Fibrosis
Akero Therapeutics, Inc 1,650
Not applicableStudy completedNCT02377947
What this trial is testing

A Retrospective, Open-label, Uncontrolled Cohort Study to Assess the Effectiveness and Safety of Lactulose Retention Enema in the Treatment of Cirrhotic Patients With Grade 3 or 4 (West Haven Criteria) Hepatic Encephalopathy (HE) [The RETRO Study]

Who this might be right for
Hepatic Encephalopathy
Abbott 50
Post-approval studies (Phase 4)Ended earlyNCT02895958
What this trial is testing

The Dublin Zepatier Study

Who this might be right for
Hepatitis C
Mater Misericordiae University Hospital 3
Large-scale testing (Phase 3)Study completedNCT02939989
What this trial is testing

Efficacy and Safety of Glecaprevir (ABT-493)/Pibrentasvir (ABT 530) (GLE/PIB) in Combination With Sofosbuvir and Ribavirin in Participants With Hepatitis C Virus Who Did Not Respond to Treatment in a Previous AbbVie Clinical Study

Who this might be right for
Hepatitis C Virus Infection
AbbVie 33
Testing effectiveness (Phase 2)Study completedNCT06342947
What this trial is testing

ALG-055009 in Non-cirrhotic Adults With MASH (HERALD)

Who this might be right for
NASHMASHMetabolic Dysfunction-Associated Steatohepatitis+1 more
Aligos Therapeutics 102
Large-scale testing (Phase 3)Active Not RecruitingNCT04007289
What this trial is testing

Apixaban for Intrahepatic Non Cirrhotic Portal Hypertension

Who this might be right for
Intrahepatic Non Cirrhotic Portal Hypertension
Assistance Publique - Hôpitaux de Paris 166
Large-scale testing (Phase 3)Study completedNCT01945294
What this trial is testing

Short Duration Versus Standard Response-Guided Therapy With Boceprevir Combined With PegIntron and Ribavirin in Previously Untreated Non-Cirrhotic Asian Participants With Chronic HCV Genotype 1 (MK-3034-107)

Who this might be right for
Hepatitis C, Chronic
Merck Sharp & Dohme LLC 257
Large-scale testing (Phase 3)Study completedNCT02707952
What this trial is testing

Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Japanese Adults With Chronic Hepatitis C Virus Infection

Who this might be right for
Chronic Hepatitis C VirusHepatitis C Virus
AbbVie 295
Testing effectiveness (Phase 2)UnknownNCT00069511
What this trial is testing

12 Week Study of Anti-Viral Effect of Oral UT-231B in Non-cirrhotic Hepatitis C Patients who have Failed Interferon-based Therapy.

Who this might be right for
Hepatitis C
United Therapeutics 72
Not applicableStudy completedNCT03852238
What this trial is testing

Risk Factors of Hepatocellular Carcinomas Developed on Non-fibrotic Liver: Case-control Study (NoFlic Study)

Who this might be right for
Hepatocellular Carcinoma
University Hospital, Bordeaux 283
Not applicableUnknownNCT02484573
What this trial is testing

Evaluation of Intestinal Permeability in Cirrhotic Patients Before and After Treatment With Non-selective Beta Blocker (Propranolol)

Who this might be right for
Liver Cirrhoses
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran 39
Not applicableStudy completedNCT05360641
What this trial is testing

Risk Factors for Recurrence of Thrombosis or Thrombotic Extension, in the Event of Acute Non-cirrhotic Portal Vein Thrombosis Secondary to a Local Cause.

Who this might be right for
Portal Vein ThrombosisLocal Cause
University Hospital, Caen 154
Testing effectiveness (Phase 2)Ended earlyNCT04023721
What this trial is testing

Evaluating the Safety and Efficacy of Inarigivir in Non-cirrhotic, Hepatitis B e Antigen-negative Subjects Infected With HBV Virus and Receiving or Stopping Treatment With a NUC Inhibitor

Who this might be right for
Hepatitis BHBVHepatitis B, Chronic
F-star Therapeutics, Inc. 64
Large-scale testing (Phase 3)Study completedNCT03069365
What this trial is testing

Evaluate the Efficacy and Safety of Glecaprevir/Pibrentasvir in Adults With Chronic Hepatitis C Virus Genotype 1 - 6 Infection and Renal Impairment

Who this might be right for
Hepatitis C Virus (HCV)
AbbVie 101
Not applicableStudy completedNCT06721845
What this trial is testing

Non-Cirrhotic Hyperammonemia Versus Hyperlactatemia in Septic Patients and Impact of Treatment

Who this might be right for
Sepsis
Menoufia University 60
Large-scale testing (Phase 3)UnknownNCT01897051
What this trial is testing

Rifaximin and Propranolol Combination Therapy Versus Propranolol Monotherapy in Cirrhotic Patients

Who this might be right for
Liver CirrhosisPortal Hypertension
Yonsei University 140
Not applicableStudy completedNCT05138523
What this trial is testing

Evaluation of the Efficacy and Safety of the Fixed-dose Combination Sofosdac® 400mg/60mg in Patients With Chronic Hepatitis C (HCV)

Who this might be right for
Chronic Hepatitis c
Beker Laboratories 99
Next Page